Article
Improvement of replication fidelity by certain mesalazine derivatives.
International journal of oncology - 1 May 2012
Honeder Clemens, Campregher Christoph, Zens Bettina, Scharl Theresa, Gasche Christoph
Abstract excerpt
Epidemiological evidence on the chemopreventive activity of mesalazine against colitis-associated cancer has accumulated in recent years. Together with the variety of mesalazine molecular antitumor effects this has prompted the development of novel mesalazine derivatives. The objective of this study was to test five novel derivatives (compounds 2-14, 2-17, 2-28,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
